News Sentiment

PBH sentiment intelligence

Prestige Brand Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 41 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 48.90 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

74/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 8

high-authority source matches

Trend context Trend inactive

-1.1% over one week, +2.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Prestige Consumer Healthcare (NYSE: PBH) issues $400M 2034 notes

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 74/100 classification
One-week reaction -1.1% Price digesting
Trend fit Trend inactive 2.3% over four weeks
Fair value -28.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 25
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 7
The Economic Times 6
TradingView 4
Quiver Quantitative 3
GlobeNewswire 3
DirectorsTalk Interviews 2
Market source 2
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 16
Deals and strategy 15
Earnings 3
Macro sensitivity 3
Balance sheet 2
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 41
Stock Titan Direct company coverage

Prestige Consumer Healthcare (NYSE: PBH) issues $400M 2034 notes

Prestige Consumer Healthcare Inc., through its subsidiary Prestige Brands, Inc., announced the issuance of $400 million of 6.250% senior unsecured notes due July 15, 2034. These notes, guaranteed by the company and its domestic restricted subsidiaries, will pay interest semiannua

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 20:10
Source
Stock Titan
TradingView Direct company coverage

PBH4913522 Bond Profile — Key Metrics

This article provides a detailed profile of the PBH4913522 corporate bond issued by Prestige Consumer Healthcare, Inc. Key metrics include a 5.125% coupon rate, a maturity date of January 15, 2028, and an outstanding amount of $400 million. The company, founded in 1996, specializ

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 12:10
Source
TradingView
DirectorsTalk Interviews Direct company coverage

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 36.61% Potential Upside in a Competitive Market

Prestige Consumer Healthcare (NYSE: PBH) is a healthcare company with a diverse portfolio of over-the-counter products, presenting a potential upside of 36.61% based on an average analyst target price of $66.80. Despite a revenue contraction, the company demonstrates resilience w

Tone
Positive 75/100
Event
Analyst action
Published
13 Jul 2026 10:23
Source
DirectorsTalk Interviews
TradingView Direct company coverage

Enterprise value to revenue forward of Prestige Consumer Healthcare Inc. – NYSE:PBH

The article focuses on the "Enterprise value to revenue forward" metric for Prestige Consumer Healthcare Inc. (NYSE: PBH) as listed on TradingView. It appears to be an entry from a financial data platform, presenting a specific financial metric for the company.

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 00:10
Source
TradingView
Stock Titan Direct company coverage

Prestige Consumer (NYSE: PBH) updates filing on OTC Wellness acquisition

Prestige Consumer Healthcare Inc. (NYSE: PBH) filed an amended Form 8-K/A to update disclosures regarding its acquisition of the OTC Wellness Business from Foundation Consumer Brands. The amendment principally removed an inadvertently included auditor review report and included u

Tone
Neutral 50/100
Event
Deals and strategy
Published
09 Jul 2026 21:10
Source
Stock Titan
AD HOC NEWS Direct company coverage

Prestige Consumer Healthcare highlights its OTC portfolio as a steady U.S. healthcare player

Prestige Consumer Healthcare (PBH) is highlighted as a stable U.S. consumer health company, focusing on a portfolio of established over-the-counter (OTC) brands like cough and cold remedies, eye care, and gastrointestinal relief. The company's strategy involves acquiring, managin

Tone
Positive 71/100
Event
Market update
Published
08 Jul 2026 17:10
Source
AD HOC NEWS
Stock Titan Direct company coverage

Ariel Investments reports 10.3% stake in Prestige Consumer Healthcare (PBH)

Ariel Investments, LLC has reported a 10.3% beneficial ownership stake in Prestige Consumer Healthcare Inc. (PBH), totaling 4,868,711 shares of Common Stock. This filing, a Schedule 13G/A amendment, indicates that Ariel holds sole voting power over 4,399,246 shares and sole dispo

Tone
Neutral 50/100
Event
Deals and strategy
Published
07 Jul 2026 14:41
Source
Stock Titan
Market source Direct company coverage

Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date

Prestige Consumer Healthcare Inc. has announced the completion of its acquisition of LaCorium Health for approximately $150 million, financed by cash on hand and existing credit facilities. The company also priced a private offering of $400 million in 6.25% senior notes due 2034,

Tone
Positive 74/100
Event
Deals and strategy
Published
07 Jul 2026 07:09
Source
Market source
Moomoo Direct company coverage

Prestige Consumer Prices Offering of $400 Million 6.25% Senior Notes Due 2034 >PBH

Prestige Consumer Healthcare Inc. (PBH) has priced an offering of $400 million in 6.25% senior notes due 2034. These notes will be issued at 100% of their face value. The offering is expected to close on July 10, 2026, subject to customary closing conditions.

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 18:39
Source
Moomoo
Investing.com Direct company coverage

Prestige Consumer Healthcare closes LaCorium acquisition for $150m

Prestige Consumer Healthcare Inc. has finalized its acquisition of LaCorium Health for approximately $150 million and also priced a $400 million senior notes offering. The acquisition of the Australian therapeutic skin care business, generating $40 million in annual revenue, is e

Tone
Positive 66/100
Event
Deals and strategy
Published
06 Jul 2026 17:39
Source
Investing.com
citybiz Direct company coverage

Prestige Consumer Healthcare Completes LaCorium Acquisition and Prices $400 Million Notes Offering

Prestige Consumer Healthcare Inc. (NYSE: PBH) has finalized its acquisition of Australian skincare company LaCorium Health for approximately $150 million. Concurrently, Prestige priced a $400 million offering of 6.25% senior notes due 2034 to refinance existing debt. The company

Tone
Positive 72/100
Event
Deals and strategy
Published
06 Jul 2026 13:12
Source
citybiz
marketscreener.com Direct company coverage

Prestige Brands, Inc. Amends Term Loan Credit Agreement and Announces Private Offering of $400 Million Senior Notes

Prestige Consumer Healthcare Inc. amended its Term Loan Credit Agreement to borrow an additional $95.0 million to finance the acquisition of LaCorium Health Australia Pty Limited and its related entities. Concurrently, the company announced a private offering of $400 million seni

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 Jul 2026 12:20
Source
marketscreener.com
Stock Titan Direct company coverage

Prestige Consumer (NYSE: PBH) closes LaCorium deal, prices $400M notes

Prestige Consumer Healthcare Inc. (NYSE: PBH) has successfully completed its acquisition of Australian skincare company LaCorium Health for approximately $150 million. The company also priced a private offering of $400 million in 6.25% senior unsecured notes due 2034, which will

Tone
Positive 64/100
Event
Deals and strategy
Published
06 Jul 2026 12:12
Source
Stock Titan
TradingView Direct company coverage

Prestige Consumer Healthcare Secures $95 Million Term Loan Amendment for LaCorium Acquisition

Prestige Consumer Healthcare (PBH) secured a $95 million term loan amendment to finance its acquisition of LaCorium, covering associated fees. The amendment was executed and became effective on July 1, 2026, with the company's subsidiary borrowing the full amount upon closing. Ci

Tone
Positive 63/100
Event
Deals and strategy
Published
06 Jul 2026 12:12
Source
TradingView
Stock Titan Direct company coverage

Prestige Consumer buys LaCorium, then prices $400M debt deal

Prestige Consumer Healthcare Inc. completed its acquisition of LaCorium Health for approximately $150 million and priced a private offering of $400 million in 6.25% senior notes due 2034. The company intends to use the proceeds from the debt offering, along with cash on hand, to

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 Jul 2026 12:12
Source
Stock Titan
Insider Monkey Direct company coverage

Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition

Prestige Consumer Healthcare Inc. (NYSE: PBH) is highlighted as a top stock by Ariel Investments following its recent acquisition of the Breathe Right brand and other brands from Foundation Consumer Healthcare for $1.045 billion. This acquisition is expected to significantly enha

Tone
Positive 73/100
Event
Deals and strategy
Published
04 Jul 2026 17:39
Source
Insider Monkey
MSN Direct company coverage

Prestige Consumer Healthcare unit plans $400M notes offering

Prestige Consumer Healthcare Inc. announced that its subsidiary, Prestige Brands, Inc., plans to offer $400 million in senior unsecured notes. The proceeds from this offering will be used to repurchase outstanding 5.375% senior notes due in 2026 and to pay related fees and expens

Tone
Neutral 50/100
Event
Capital return
Published
01 Jul 2026 23:39
Source
MSN
Moomoo Direct company coverage

Prestige Plans $400 Million Private Offering of Senior Notes

Prestige Brands Holdings, Inc. announced a private offering of $400 million in senior notes due 2024 to eligible purchasers. The company plans to use the net proceeds from this offering, along with borrowings under its revolving credit facility, to redeem all of its outstanding 8

Tone
Positive 63/100
Event
Balance sheet
Published
30 Jun 2026 14:41
Source
Moomoo
Quiver Quantitative Direct company coverage

Prestige Consumer Healthcare Announces Proposed Private Offering of $400 Million Senior Notes Due 2034 to Redeem 2028 Notes

Prestige Consumer Healthcare Inc. is planning a private offering of $400 million in senior notes due 2034 through its subsidiary, Prestige Brands, to qualified institutional buyers. The proceeds from this offering will be used to redeem all outstanding 5.125% Senior Notes due 202

Tone
Positive 63/100
Event
Market update
Published
30 Jun 2026 12:41
Source
Quiver Quantitative
TradingView Direct company coverage

Prestige Consumer Healthcare Inc. Announces Offering Of $400 Million Senior Notes

Prestige Consumer Healthcare Inc. has announced an offering of $400 million in senior notes. This brief report, sourced from Reuters and Refinitiv, indicates a financial move by the company. Further details are not provided in this short news piece.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 12:41
Source
TradingView
Stock Titan Direct company coverage

Prestige Consumer lines up $400M debt refinancing due 2034

Prestige Consumer Healthcare (NYSE: PBH) through its subsidiary Prestige Brands, plans a private offering of up to $400 million in senior unsecured notes due 2034. The net proceeds, along with cash on hand, will be used to redeem all of Prestige Brands' existing $400 million 5.12

Tone
Neutral 50/100
Event
Balance sheet
Published
30 Jun 2026 12:41
Source
Stock Titan
Stock Titan Direct company coverage

[8-K/A] Prestige Consumer Healthcare Inc. Amends Material Event Report

Prestige Consumer Healthcare Inc. (PBH) has filed an amended 8-K report to provide comprehensive historical and unaudited pro forma financial statements for its $1,045.0 million acquisition of the OTC Wellness Business, including Breathe Right, from Foundation Consumer Brands. Th

Tone
Positive 64/100
Event
Deals and strategy
Published
30 Jun 2026 09:41
Source
Stock Titan
Quiver Quantitative Direct company coverage

Prestige Consumer Healthcare Inc. ($PBH) Chair, President, and CEO 2026 Pay Revealed

Prestige Consumer Healthcare Inc.'s CEO, Ronald M. Lombardi, is estimated to have received $6,004,547 in compensation in 2026, a 3.14% decrease from 2025. This compensation information is based on a new DEF14A SEC filing. The article also details insider trading activities, hedge

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 22:25
Source
Quiver Quantitative
www.marketscreener.com Direct company coverage

Prestige Consumer Healthcare Inc.(NYSE:PBH) dropped from Russell 3000E Growth Benchmark

Prestige Consumer Healthcare Inc. (NYSE: PBH) has been removed from the Russell 3000E Growth Benchmark. This news follows a series of recent events for the company, including the acquisition of Breathe Right, new product announcements for Dramamine, and soft Q4 2026 earnings resu

Tone
Neutral 50/100
Event
Deals and strategy
Published
29 Jun 2026 05:39
Source
www.marketscreener.com
GlobeNewswire Direct company coverage

Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, Hagens Berman Investigating

Hagens Berman is investigating Prestige Consumer Healthcare (PBH) after its stock fell over 11% due to disappointing Q4 2026 financial results, including significant revenue declines and production issues at its Pillar5 facility, which impacts the Clear Eyes® brand. The investiga

Tone
Negative 20/100
Event
Earnings
Published
26 Jun 2026 07:10
Source
GlobeNewswire